Need Help?
Article Versions Notes
| Action | Date | Notes | Link |
|---|---|---|---|
| article pdf uploaded. | 13 December 2025 10:13 CET | Version of Record | https://www.mdpi.com/2077-0383/14/24/8831/pdf |
Cite
Blizou, M.; Lampadakis, S.; Karofylakis, E.; Blizou, A.; Thomas, K.; Prountzos, S.; Papavasileiou, V.; Raptakis, T.; Manali, E.D.; Papiris, S.A.; et al. Combination Treatment of Persistent SARS-CoV-2 Infection with Dual Antiviral Therapy and Intravenous Immunoglobulin: A Novel Approach. J. Clin. Med. 2025, 14, 8831. https://doi.org/10.3390/jcm14248831
Blizou M, Lampadakis S, Karofylakis E, Blizou A, Thomas K, Prountzos S, Papavasileiou V, Raptakis T, Manali ED, Papiris SA, et al. Combination Treatment of Persistent SARS-CoV-2 Infection with Dual Antiviral Therapy and Intravenous Immunoglobulin: A Novel Approach. Journal of Clinical Medicine. 2025; 14(24):8831. https://doi.org/10.3390/jcm14248831
Chicago/Turabian StyleBlizou, Myrto, Stefanos Lampadakis, Emmanouil Karofylakis, Andromachi Blizou, Konstantinos Thomas, Spyridon Prountzos, Vasileios Papavasileiou, Thomas Raptakis, Effrosyni D. Manali, Spyros A. Papiris, and et al. 2025. "Combination Treatment of Persistent SARS-CoV-2 Infection with Dual Antiviral Therapy and Intravenous Immunoglobulin: A Novel Approach" Journal of Clinical Medicine 14, no. 24: 8831. https://doi.org/10.3390/jcm14248831
APA StyleBlizou, M., Lampadakis, S., Karofylakis, E., Blizou, A., Thomas, K., Prountzos, S., Papavasileiou, V., Raptakis, T., Manali, E. D., Papiris, S. A., Loukides, S., & Antonogiannaki, E.-M. (2025). Combination Treatment of Persistent SARS-CoV-2 Infection with Dual Antiviral Therapy and Intravenous Immunoglobulin: A Novel Approach. Journal of Clinical Medicine, 14(24), 8831. https://doi.org/10.3390/jcm14248831
